Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ1X | ISIN: CA0717341071 | Ticker-Symbol: BVF
Tradegate
17.04.25
20:20 Uhr
4,555 Euro
+0,066
+1,47 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BAUSCH HEALTH COMPANIES INC Chart 1 Jahr
5-Tage-Chart
BAUSCH HEALTH COMPANIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,4684,51017.04.
4,4684,51017.04.

Aktuelle News zur BAUSCH HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoBausch Health shares jump on favorable court ruling1
DoBausch Health-Aktien steigen nach positivem Gerichtsurteil5
DoBausch Health Companies Inc: Bausch "pleased" with court judgment against Norwich2
DoBausch Health Companies Inc.: U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich1.619LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today...
► Artikel lesen
DoFitch hebt Bausch Health-Rating auf CCC+7
DoFitch raises Bausch Health rating to CCC+ amid refinancing5
DiBausch Health Companies Inc. - 8-K, Current Report1
DiBausch Health Companies Inc. - 8-A12B, Registration of securities3
BAUSCH HEALTH Aktie jetzt für 0€ handeln
DiBausch Health Companies Inc: Bausch Health swallows poison pill, no offers in sight5
MoBausch Health Companies Inc.: Bausch Health Announces Adoption of Shareholder Rights Plan295LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approved...
► Artikel lesen
10.04.Bausch Health Companies Inc: Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program266Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / Bausch...
► Artikel lesen
09.04.Bausch Health Companies Inc: Bausch Health seeks Canadian coverage for acne medicine8
09.04.Bausch Health secures intent for acne treatment coverage4
09.04.Bausch Health Companies Inc.: Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of CABTREO Treatment for Acne Vulgaris263LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Canadian...
► Artikel lesen
07.04.Bausch Health stock target cut to $8.50 by RBC Capital4
02.04.Bausch Health Companies Inc.: Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month167Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagnosed...
► Artikel lesen
27.03.Bausch Health Companies Inc: Bausch Health to release Q1 2025 results April 304
27.03.Bausch Health Companies Inc: Bausch Health to Announce First Quarter Results on April 30236LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health...
► Artikel lesen
25.03.Bausch Health upsizes senior notes offering to $4.4 billion11
25.03.Bausch Health erhöht Angebot für vorrangige Anleihen auf 4,4 Milliarden US-Dollar13
Seite:  Weiter >>
95 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,13